5-Layer StackThe Clav Protocol
−28.7%Retatrutide Phase 2
11 TotalStack Compounds
>98%HPLC Purity
$200+Free Shipping
ApolloVerified Supplier
Research Areas
Skin Research

GLOW & Skin Protocol

GHK-CU (GLOW) and SNAP-8 (KLOW) — the skin aesthetic layer. Collagen synthesis, remodeling, and expression wrinkle research.

4,000+
Genes upregulated (GHK-CU)
Broad Institute 2012
70%
Collagen I increase
Fibroblast models
63%
Wrinkle depth reduction
SNAP-8 preclinical models
−60%
GHK-CU plasma decline by 60
vs age-20 levels

Mechanism of Action

Collagen Synthesis (GHK-CU)

GHK-CU upregulates Type I, III, VI collagen synthesis in fibroblasts — 70%+ increase in preclinical models. Simultaneously activates MMPs to remove damaged collagen while TIMP-1 protects new collagen.

VEGF Angiogenesis (GHK-CU)

VEGF upregulation drives new capillary formation in dermal tissue. Increased capillary density improves oxygenation and nutrient delivery — the physical basis of the luminosity/GLOW effect.

NMJ ACh Inhibition (SNAP-8)

SNAP-8 competes with SNAP-25 for SNARE complex binding at the neuromuscular junction, partially inhibiting ACh release. Lower contraction force → reduced expression wrinkle deepening.

GLOW & Skin: The Aesthetic Layer

Losing 28% body weight produces visible skin changes — both positive (facial definition) and challenging (skin laxity, collagen disruption). The Clav stack addresses this with two distinct skin peptides.

GHK-CU: GLOW Peptide

GHK-CU (glycyl-L-histidyl-L-lysine copper) is the most-studied injectable skin peptide in preclinical research. Clavicular calls it the GLOW peptide.

Key research findings:

  • Upregulates 4,000+ genes involved in skin biology (Broad Institute)
  • 70% increase in Type I, III, VI collagen in fibroblast models
  • VEGF-driven angiogenesis → increased capillary density → luminosity
  • Cu-SOD activation → antioxidant defense
  • MMP activation removes damaged collagen while TIMP-1 protects new collagen
  • Hair follicle: VEGF upregulation in dermal papilla
Natural plasma GHK-CU declines from ~200 ng/mL at age 20 to ~80 ng/mL by 60. The Clav stack uses it to compensate for this decline and counteract fat-loss-related skin changes.

SNAP-8: KLOW Peptide

SNAP-8 (acetyl octapeptide-3) is a SNAP-25 N-terminal analog. It competes for SNARE complex binding at the neuromuscular junction, partially inhibiting ACh release → reducing expression muscle contraction force → reducing dynamic wrinkle depth.

Preclinical data: up to 63% reduction in expression wrinkle depth.

GHK-CU + SNAP-8 together:

  • GHK-CU: structural collagen biology
  • SNAP-8: neuromuscular wrinkle mechanism
Completely different pathways, fully synergistic.

Frequently Asked Questions

What is the GLOW peptide?

GHK-CU — a copper-complexed tripeptide that upregulates collagen synthesis genes, drives skin remodeling via matrix metalloproteinase activation, increases capillary density through VEGF upregulation, and activates Cu-SOD antioxidant defense. Clavicular's primary skin compound.

What is the KLOW peptide?

SNAP-8 (acetyl octapeptide-3) — a SNAP-25 analog that partially inhibits ACh release at facial NMJ, reducing the force of expression muscle contractions and the deepening of dynamic wrinkles.

Build the Clav Stack

Research-grade compounds from Apollo Peptide Sciences. The Official Protocol. The Only Stack.